Medoz Pharmaceuticals Private Limited, a active private limited company, was established on 02 February 2000 in Vadodara, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231GJ2000PTC037288. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹6.21 M.
It upholds a compliant status. Employing 38 professional, Its leadership includes Parmar Rameshkumar (Director), Rakesh Jambuprasad Agrawal (Managing Director). Past directors included Jambukumar Jain, Nandkishore Maheshwari, Anil Kumar Agarwal. It holds ₹7.26 Cr open charges and ₹4.98 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 418,Payal Complex,Sayajigunj, Vadodara, Gujarat, 390020.
U24231GJ2000PTC037288
037288
02 February 2000
₹1.00 Cr
₹6.21 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Medoz Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Parmar Rameshkumar | Director | 18 Sep 2019 | Current |
| Rakesh Jambuprasad Agrawal | Managing Director | 02 Feb 2000 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 10 Apr 2019 | Past |
| Pramod Abcsdd | Director | 10 Apr 2019 | Past |
| Pramod Abcsdd | Director | 16 Dec 2019 | Past |
| Pramod Abcsdd | Director | 30 Sep 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Medoz Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 11.13% increase. The company also saw a slight improvement in profitability, with a 2.53% increase in profit. The company's net worth moved up by a moderate rise of 5.42%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Medoz Pharmaceuticals had a public holding of 26.99%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹72,609,000.00
₹49,800,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Jul 2024 | Others | ₹1.96 M | Open |
| 02 Nov 2020 | Canara Bank | ₹1.70 M | Open |
| 25 Sep 2019 | Others | ₹6.60 Cr | Open |
| 21 Feb 2011 | Director Of Industries Himachal Pradesh | ₹3.00 M | Open |
| 09 Mar 2021 | Hdfc Bank Limited | ₹3.39 Cr | Satisfied |
Explore comprehensive loan charge details -
Medoz Pharmaceuticals has a workforce of 38 employees as of Feb 28, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Medoz Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medoz Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Medoz Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
Progress on Medoz Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was documented.
The activity A charge with Others amounted to Rs. 0.20 Cr with Charge ID 100966810 was registered on 24 Jul 2024. was completed.
The activity A charge with Others of Rs. 6.60 Cr registered on 25 Sep 2019 with Charge ID 100289988 was modified on 22 Jul 2024. was completed.
Progress on A charge registered on 09 Mar 2021 via Charge ID 100444656 with Hdfc Bank Limited was fully satisfied on 22 Apr 2022. was documented.
The activity A charge with Hdfc Bank Limited amounted to Rs. 3.39 Cr with Charge ID 100444656 was registered on 09 Mar 2021. was completed.
The CIN of Medoz Pharmaceuticals Private Limited is U24231GJ2000PTC037288.
Medoz Pharmaceuticals Private Limited is headquartered at 418,Payal Complex,Sayajigunj, Vadodara, Gujarat, 390020.
Medoz Pharmaceuticals Private Limited was incorporated on 02 February 2000.
The current directors of Medoz Pharmaceuticals Private Limited are
The primary industry of Medoz Pharmaceuticals Private Limited is Manufacturing.
Medoz Pharmaceuticals Private Limited is unlisted.
The authorized capital of Medoz Pharmaceuticals Private Limited is ₹1.00 Cr, and the paid-up capital is ₹6.21 M.
The compliance status of Medoz Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX